[
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_641",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_642",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_643",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_644",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_645",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_646",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_647",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_648",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_649",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_650",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_651",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_652",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_653",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_654",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_655",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_656",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_657",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_658",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_659",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_660",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_661",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_662",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_663",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_664",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_665",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_666",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_667",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_668",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_669",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_670",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_671",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_672",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_673",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_674",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_675",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_676",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_677",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_678",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_679",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_680",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_681",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_682",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_683",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_684",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_685",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_686",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_687",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_688",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_689",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_690",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_691",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_692",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_693",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_694",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_695",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_696",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_697",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_698",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_699",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_700",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_701",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_702",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_703",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_704",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_705",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_706",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_707",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_708",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_709",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_710",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_711",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_712",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_713",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_714",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_715",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_716",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_717",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_718",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_719",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_720",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_721",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_722",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_723",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_724",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_725",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_726",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_727",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_728",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_729",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_730",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_641",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_642",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_643",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_644",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_645",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_646",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_647",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_648",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_649",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_650",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_651",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_652",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_653",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_654",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_655",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_656",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_657",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_658",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_659",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_660",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_661",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_662",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_663",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_664",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_665",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_666",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_667",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_668",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_669",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_670",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_671",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_672",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_673",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_674",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_675",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_676",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_677",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_678",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_679",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_680",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_681",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_682",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_683",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_684",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_685",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_686",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_687",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_688",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_689",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_690",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_691",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_692",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_693",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_694",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_695",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_696",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_697",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_698",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_699",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_700",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_701",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_702",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_703",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_704",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_705",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_706",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_707",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_708",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_709",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_710",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_711",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_712",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_713",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_714",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_715",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_716",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_717",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_718",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_719",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_720",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_721",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_722",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_723",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_724",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_725",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_726",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_727",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_728",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_729",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_730",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_641",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_642",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_643",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_644",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_645",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_646",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_647",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_648",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_649",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_650",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_651",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_652",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_653",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_654",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_655",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_656",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_657",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_658",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_659",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_660",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_661",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_662",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_663",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_664",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_665",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_666",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_667",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_668",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_669",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_670",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_671",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_672",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_673",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_674",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_675",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_676",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_677",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_678",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_679",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_680",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_681",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_682",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_683",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_684",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_685",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_686",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_687",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_688",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_689",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_690",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_691",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_692",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_693",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_694",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_695",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_696",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_697",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_698",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_699",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_700",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_701",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_702",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_703",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_704",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_705",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_706",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_707",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_708",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_709",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_710",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_711",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_712",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_713",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_714",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_715",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_716",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_717",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_718",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_719",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_720",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_721",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_722",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_723",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_724",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_725",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_726",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_727",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_728",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_729",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_730",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_731",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_732",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_733",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_734",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_735",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_736",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_737",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_738",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_739",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_740",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_741",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_742",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_743",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_744",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_745",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_746",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_747",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_748",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_749",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_750",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_751",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_752",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_753",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_754",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_755",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_756",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_757",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_758",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_759",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_760",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_761",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_762",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_763",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_764",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_765",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_766",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_767",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_768",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_769",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_770",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_771",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_772",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_773",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_774",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_775",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_776",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_777",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_778",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_779",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_780",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_781",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_782",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_783",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_784",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_785",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_786",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_787",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_788",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_789",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_790",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_791",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_792",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_793",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_794",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_795",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_796",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_797",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_798",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_799",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_800",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_801",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_802",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_803",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_804",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_805",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_806",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_807",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_808",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_809",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_810",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_811",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_812",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_813",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_814",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_815",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_816",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_817",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_818",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_819",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_820",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_731",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_732",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_733",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_734",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_735",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_736",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_737",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_738",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_739",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_740",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_741",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_742",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_743",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_744",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_745",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_746",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_747",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_748",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_749",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_750",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_751",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_752",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_753",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_754",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_755",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_756",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_757",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_758",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_759",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_760",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_761",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_762",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_763",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_764",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_765",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_766",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_767",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_768",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_769",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_770",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_771",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_772",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_773",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_774",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_775",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_776",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_777",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_778",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_779",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_780",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_781",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_782",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_783",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_784",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_785",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_786",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_787",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_788",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_789",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_790",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_791",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_792",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_793",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_794",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_795",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_796",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_797",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_798",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_799",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_800",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_801",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_802",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_803",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_804",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_805",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_806",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_807",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_808",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_809",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_810",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_811",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_812",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_813",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_814",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_815",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_816",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_817",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_818",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_819",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_820",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_821",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_822",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_823",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_824",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_825",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_826",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_827",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_828",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_829",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_830",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_831",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_832",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_833",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_834",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_835",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_836",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_837",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_838",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_839",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_840",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_841",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_842",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_843",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_844",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_845",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_846",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_847",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_848",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_849",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_850",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_851",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_852",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_853",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_854",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_855",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_856",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_857",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_858",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_859",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_860",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_861",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_862",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_863",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_864",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_865",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_866",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_867",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_868",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_869",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_870",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_871",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_872",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_873",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_874",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_875",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_876",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_877",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_878",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_879",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_880",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_41",
        "submitter_treatment_id": "TREATMENT_881",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_42",
        "submitter_treatment_id": "TREATMENT_882",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_43",
        "submitter_treatment_id": "TREATMENT_883",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_44",
        "submitter_treatment_id": "TREATMENT_884",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_45",
        "submitter_treatment_id": "TREATMENT_885",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_46",
        "submitter_treatment_id": "TREATMENT_886",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_47",
        "submitter_treatment_id": "TREATMENT_887",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_48",
        "submitter_treatment_id": "TREATMENT_888",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_49",
        "submitter_treatment_id": "TREATMENT_889",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_50",
        "submitter_treatment_id": "TREATMENT_890",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_51",
        "submitter_treatment_id": "TREATMENT_891",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_52",
        "submitter_treatment_id": "TREATMENT_892",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_53",
        "submitter_treatment_id": "TREATMENT_893",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_54",
        "submitter_treatment_id": "TREATMENT_894",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_55",
        "submitter_treatment_id": "TREATMENT_895",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_56",
        "submitter_treatment_id": "TREATMENT_896",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_57",
        "submitter_treatment_id": "TREATMENT_897",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_58",
        "submitter_treatment_id": "TREATMENT_898",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_59",
        "submitter_treatment_id": "TREATMENT_899",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_60",
        "submitter_treatment_id": "TREATMENT_900",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_61",
        "submitter_treatment_id": "TREATMENT_901",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_62",
        "submitter_treatment_id": "TREATMENT_902",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_63",
        "submitter_treatment_id": "TREATMENT_903",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_64",
        "submitter_treatment_id": "TREATMENT_904",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_65",
        "submitter_treatment_id": "TREATMENT_905",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_66",
        "submitter_treatment_id": "TREATMENT_906",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_67",
        "submitter_treatment_id": "TREATMENT_907",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_68",
        "submitter_treatment_id": "TREATMENT_908",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_69",
        "submitter_treatment_id": "TREATMENT_909",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_70",
        "submitter_treatment_id": "TREATMENT_910",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 70
    }
]